Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

KalVista Pharmaceuticals (KALV) Profit After Tax: 2014-2025

Historic Profit After Tax for KalVista Pharmaceuticals (KALV) over the last 7 years, with Apr 2025 value amounting to -$42.3 million.

  • KalVista Pharmaceuticals' Profit After Tax rose 5.34% to -$42.3 million in Q2 2025 from the same period last year, while for Apr 2025 it was -$156.4 million, marking a year-over-year decrease of 74.63%. This contributed to the annual value of -$183.4 million for FY2025, which is 44.85% down from last year.
  • KalVista Pharmaceuticals' Profit After Tax amounted to -$42.3 million in Q2 2025, which was down 4.51% from -$40.4 million recorded in Q3 2024.
  • KalVista Pharmaceuticals' 5-year Profit After Tax high stood at -$29.0 million for Q1 2024, and its period low was -$44.6 million during Q2 2024.
  • Its 2-year average for Profit After Tax is -$39.1 million, with a median of -$41.4 million in 2024.
  • Data for KalVista Pharmaceuticals' Profit After Tax shows a peak YoY increased of 5.34% (in 2025) over the last 5 years.
  • Quarterly analysis of 2 years shows KalVista Pharmaceuticals' Profit After Tax stood at -$40.4 million in 2024, then increased by 5.34% to -$42.3 million in 2025.
  • Its Profit After Tax was -$42.3 million in Q2 2025, compared to -$40.4 million in Q3 2024 and -$44.6 million in Q2 2024.